Clinical trials
Observational Hyperlipidemias trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 4 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 4 |
| Unknown status | 3 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ohio State University | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Vanderbilt University Medical Center | 2 |
| Baltimore VA Medical Center | 1 |
| Baystate Medical Center | 1 |
| Cedars-Sinai Medical Center | 1 |
| Duke University | 1 |
| Emory University | 1 |
| Esperion Therapeutics, Inc. | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 27 |
| Diabetes Mellitus | 7 |
| Hypertension | 6 |
| Cardiovascular Diseases | 5 |
| Dyslipidemias | 5 |
| Hypercholesterolemia | 5 |
| Atherosclerosis | 4 |
| Obesity | 3 |
| Coronary Artery Disease | 2 |
| Diabetes Mellitus, Type 2 | 2 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.